Filter by: Subject

Filter by: Subject

Results Per Page:

South Africa (SA) (5)
SDG-03: Good health and well-being (4)
Acute pancreatitis (AP) (2)
Benefits (2)
Colorectal cancer (CRC) (2)
Harms (2)
Immunology (2)
Interleukins (2)
Pancreas (2)
Pancreatic ductal adenocarcinoma (PDAC) (2)
Surgical portosystemic shunts (2)
Variceal rebleeding (2)
Abdominal injuries (1)
Abdominal trauma (1)
Acute inflammation (1)
Acute pancreatitis (1)
Africa (1)
Alcohol (1)
Anastomotic leak (1)
Antibiotics (1)
Cancer surgery (1)
Chronic calcific pancreatitis (1)
Cirrhosis (1)
Cirrhotic portal hypertension (1)
Colorectal anastomotic leak (CAL) (1)
Colorectal surgery (1)
Coronavirus disease 2019 (COVID-19) (1)
COVID-19 pandemic (1)
CRC liver metastases (CRCLM) (1)
Critically ill patients (1)
Diabetes mellitus (1)
Dysregulated pathways (1)
Elective surgery (1)
Epidermal growth factor receptor (EGFR) (1)
Gallstone disease (1)
Gene expression (1)
Hepatosplenic schistosomiasis (1)
Hospital admissions (1)
Hypertension (1)
Infected pancreatic necrosis (1)
Injury (1)
Insulin‑like growth factor (IGF) (1)
Interleukin-21 (IL-21) (1)
Junction plakoglobin (JUP) (1)
Let-7 (1)
Liver metastasis (1)
Lockdown (1)
Low (1)
Lung metastasis (1)
Lymphopenia (1)
MAPK signalling (1)
Messenger RNA (mRNA) (1)
MicroRNA (miRNA) (1)
Mitogen‑activated protein kinase (MAPK) (1)
Mortality (1)
National Cancer Registry (NCR) (1)
Necrosectomy (1)
Necroza pancreatica infectata (1)
Necrozectomie (1)
Non-selective shunt (1)
P13K/AKT (1)
Pancreatic adenocarcinoma (PDAC) (1)
Pancreatic necrosis (1)
Pancreaticobiliary malignancy (1)
Pancreatita (1)
Pancreatitis (1)
Patients (1)
Penetrating trauma (1)
People (1)
Plakoglobin (γ‑catenin) (1)
Polydioxanone suture (PDS) (1)
Portal hypertension (1)
Prevention (1)
Selective shunt (1)
Sepsis (1)
Severe acute pancreatitis (SAP) (1)
Smoking (1)
Systemic inflammatory response syndrome (SIRS) (1)
Transjugular intrahepatic portosystemic shunt (TIPS) (1)
Urbanization (1)
Variceal haemorrhage (1)